Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone

Nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids (GCs) are often used to treat articular-skeletal disorders. The extended use of NSAIDs and GCs have adverse effects on bone metabolism, reducing bone quality and impairing fracture healing. In the present study, we used mouse pre-oste...

Full description

Bibliographic Details
Main Authors: Tomasz P. Lehmann, Ewa Iwańczyk-Skalska, Jerzy Harasymczuk, Paweł P. Jagodziński, Maciej Głowacki
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/14/1/184
_version_ 1797442011317403648
author Tomasz P. Lehmann
Ewa Iwańczyk-Skalska
Jerzy Harasymczuk
Paweł P. Jagodziński
Maciej Głowacki
author_facet Tomasz P. Lehmann
Ewa Iwańczyk-Skalska
Jerzy Harasymczuk
Paweł P. Jagodziński
Maciej Głowacki
author_sort Tomasz P. Lehmann
collection DOAJ
description Nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids (GCs) are often used to treat articular-skeletal disorders. The extended use of NSAIDs and GCs have adverse effects on bone metabolism, reducing bone quality and impairing fracture healing. In the present study, we used mouse pre-osteoblast cells MC3T3-E1 to demonstrate the effects of diclofenac (DF) and methylprednisolone (MP) on cell proliferation and gene expression. Cells were incubated with three doses of DF or MP: 0.5 µM, 5 µM, and 50 µM. MP decreased cell viability even after 24 h, but DF inhibited cell viability after only seven days of treatment. The cells were lysed after one, two, three, and seven days of treatment, and gene expression was analyzed by reverse transcription and quantitative PCR (RT-qPCR) assays. DF did not significantly affect the expression of the osteogenic marker genes. MP modified the expression of <i>Osx</i>, <i>Runx</i>, and <i>Col1a1</i>. We concluded that MP is a more potent inhibitor of mouse pre-osteoblast differentiation and viability than is DF. Our results suggest that prolonged DF treatment could be less harmful to osteoblasts than MP treatment.
first_indexed 2024-03-09T12:35:51Z
format Article
id doaj.art-5bd0fe6c02674a11a6eb00e6e580b9fd
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-09T12:35:51Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-5bd0fe6c02674a11a6eb00e6e580b9fd2023-11-30T22:24:50ZengMDPI AGGenes2073-44252023-01-0114118410.3390/genes14010184Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and MethylprednisoloneTomasz P. Lehmann0Ewa Iwańczyk-Skalska1Jerzy Harasymczuk2Paweł P. Jagodziński3Maciej Głowacki4Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Święcickiego 6, 60-781 Poznan, PolandDepartment of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Święcickiego 6, 60-781 Poznan, PolandDepartment of Paediatric Surgery, Traumatology and Urology, Poznan University of Medical Sciences, Szpitalna 27/33, 60-572 Poznan, PolandDepartment of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Święcickiego 6, 60-781 Poznan, PolandDepartment of Paediatric Orthopaedics and Traumatology, Poznan University of Medical Sciences, 28 Czerwca 1956 135/147, 61-545 Poznan, PolandNonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids (GCs) are often used to treat articular-skeletal disorders. The extended use of NSAIDs and GCs have adverse effects on bone metabolism, reducing bone quality and impairing fracture healing. In the present study, we used mouse pre-osteoblast cells MC3T3-E1 to demonstrate the effects of diclofenac (DF) and methylprednisolone (MP) on cell proliferation and gene expression. Cells were incubated with three doses of DF or MP: 0.5 µM, 5 µM, and 50 µM. MP decreased cell viability even after 24 h, but DF inhibited cell viability after only seven days of treatment. The cells were lysed after one, two, three, and seven days of treatment, and gene expression was analyzed by reverse transcription and quantitative PCR (RT-qPCR) assays. DF did not significantly affect the expression of the osteogenic marker genes. MP modified the expression of <i>Osx</i>, <i>Runx</i>, and <i>Col1a1</i>. We concluded that MP is a more potent inhibitor of mouse pre-osteoblast differentiation and viability than is DF. Our results suggest that prolonged DF treatment could be less harmful to osteoblasts than MP treatment.https://www.mdpi.com/2073-4425/14/1/184MC3T3diclofenacmethylprednisoloneglucocorticoidnonsteroidal anti-inflammatory drugs
spellingShingle Tomasz P. Lehmann
Ewa Iwańczyk-Skalska
Jerzy Harasymczuk
Paweł P. Jagodziński
Maciej Głowacki
Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
Genes
MC3T3
diclofenac
methylprednisolone
glucocorticoid
nonsteroidal anti-inflammatory drugs
title Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
title_full Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
title_fullStr Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
title_full_unstemmed Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
title_short Gene Expression in MC3T3-E1 Cells Treated with Diclofenac and Methylprednisolone
title_sort gene expression in mc3t3 e1 cells treated with diclofenac and methylprednisolone
topic MC3T3
diclofenac
methylprednisolone
glucocorticoid
nonsteroidal anti-inflammatory drugs
url https://www.mdpi.com/2073-4425/14/1/184
work_keys_str_mv AT tomaszplehmann geneexpressioninmc3t3e1cellstreatedwithdiclofenacandmethylprednisolone
AT ewaiwanczykskalska geneexpressioninmc3t3e1cellstreatedwithdiclofenacandmethylprednisolone
AT jerzyharasymczuk geneexpressioninmc3t3e1cellstreatedwithdiclofenacandmethylprednisolone
AT pawełpjagodzinski geneexpressioninmc3t3e1cellstreatedwithdiclofenacandmethylprednisolone
AT maciejgłowacki geneexpressioninmc3t3e1cellstreatedwithdiclofenacandmethylprednisolone